BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12855658)

  • 1. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines.
    Duan Z; Duan Y; Lamendola DE; Yusuf RZ; Naeem R; Penson RT; Seiden MV
    Clin Cancer Res; 2003 Jul; 9(7):2778-85. PubMed ID: 12855658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MM-TRAG (MGC4175), a novel intracellular mitochondrial protein, is associated with the taxol- and doxorubicin-resistant phenotype in human cancer cell lines.
    Duan Z; Brakora KA; Seiden MV
    Gene; 2004 Sep; 340(1):53-9. PubMed ID: 15556294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line.
    Duan Z; Feller AJ; Toh HC; Makastorsis T; Seiden MV
    Gene; 1999 Mar; 229(1-2):75-81. PubMed ID: 10095106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.
    Duan Z; Lamendola DE; Penson RT; Kronish KM; Seiden MV
    Cytokine; 2002 Mar; 17(5):234-42. PubMed ID: 12027404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the TRAG-3 gene in human esophageal cancer: the frequent synchronous expression of MAGE-3 gene.
    Ohta M; Tanaka F; Sadanaga N; Yamaguchi H; Inoue H; Mori M
    Oncol Rep; 2006 Jun; 15(6):1529-32. PubMed ID: 16685391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, Interferon-gamma, taxol and gamma-irradiation.
    Cilensek ZM; Yehiely F; Kular RK; Deiss LP
    Cancer Biol Ther; 2002; 1(4):380-7. PubMed ID: 12432251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.
    Duan Z; Feller AJ; Penson RT; Chabner BA; Seiden MV
    Clin Cancer Res; 1999 Nov; 5(11):3445-53. PubMed ID: 10589757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer/testis antigen CSAGE is concurrently expressed with MAGE in chondrosarcoma.
    Lin C; Mak S; Meitner PA; Wolf JM; Bluman EM; Block JA; Terek RM
    Gene; 2002 Feb; 285(1-2):269-78. PubMed ID: 12039054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy. Laboratory investigation.
    Kasuga C; Nakahara Y; Ueda S; Hawkins C; Taylor MD; Smith CA; Rutka JT
    J Neurosurg Pediatr; 2008 Apr; 1(4):305-13. PubMed ID: 18377306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines.
    Zhang S; Zhou X; Yu H; Yu Y
    BMC Cancer; 2010 Apr; 10():163. PubMed ID: 20423514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy.
    Gjerstorff MF; Johansen LE; Nielsen O; Kock K; Ditzel HJ
    Br J Cancer; 2006 Jun; 94(12):1864-73. PubMed ID: 16773077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma.
    Feller AJ; Duan Z; Penson R; Toh HC; Seiden MV
    Anticancer Res; 2000; 20(6B):4147-51. PubMed ID: 11205240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines.
    Duan Z; Lamendola DE; Duan Y; Yusuf RZ; Seiden MV
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):277-85. PubMed ID: 15565326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer.
    Suzuki T; Yoshida K; Wada Y; Hamai Y; Sentani K; Oue N; Yasui W
    Oncol Rep; 2007 Aug; 18(2):329-36. PubMed ID: 17611652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.
    Lamendola DE; Duan Z; Yusuf RZ; Seiden MV
    Cancer Res; 2003 May; 63(9):2200-5. PubMed ID: 12727840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer.
    Duan Z; Weinstein EJ; Ji D; Ames RY; Choy E; Mankin H; Hornicek FJ
    Mol Cancer Ther; 2008 Aug; 7(8):2377-85. PubMed ID: 18687998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
    Jensen PB; Holm B; Sorensen M; Christensen IJ; Sehested M
    Br J Cancer; 1997; 75(6):869-77. PubMed ID: 9062409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression.
    Bertram J; Palfner K; Hiddemann W; Kneba M
    Anticancer Drugs; 1998 Apr; 9(4):311-7. PubMed ID: 9635921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A; Soprano DR; Parekh HK
    Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.